Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Cardiome Pharma Corp (NASDAQ:CORV.DL)

CAPS Rating: No stars

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CORV.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Hotpicks101 (28.32)
Submitted December 14, 2010

Just following some other highly ranked players. Didn't do any other due diligence.

zzlangerhans (98.83)
Submitted April 14, 2013

Cardiome should be given credit for wriggling out of their heavy debt to Merck by paying only 40% of what they owed, but now they have to face a very uncertain future with only 28M in cash and a single asset that no one seems to want. When I saw that… More

NASDAQ:CORV.DL VS S&P 500 (SPY)

NASDAQ:CORV.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CORV.DL.

No one has written a Pitch for CORV.DL stock yet. Tell us why you think CORV.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CORV.DL.

No players have picked CORV.DL yet. Tell us why you think CORV.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CORV.DL.